Yabao Pharmaceutical Group Co.,Ltd — Investor Relations & Filings
Filings indexed
1,354
across all filing types
Latest filing
2026-05-15
Regulatory Filings
Country
CN
China
Listing
Shanghai Stock Exchange
600351
Yabao Pharmaceutical Group Co.,Ltd. focuses on the research, development, manufacturing, and commercialization of pharmaceutical products. The company maintains a specialized portfolio across therapeutic areas including pediatrics, cardiovascular health, and endocrinology. Key offerings include traditional Chinese medicines, chemical drugs, and innovative transdermal patches, such as the Dinggui Erqi Patch. The organization operates integrated production bases and research facilities dedicated to advancing drug delivery systems and biotechnological applications. Its business model emphasizes the modernization of traditional therapies alongside the development of conventional pharmaceuticals to address diverse clinical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 亚宝药业集团股份有限公司关于参加山西辖区上市公司2026年投资者网上集体接待日活动的公告 | 2026-05-15 | Chinese | |
| 亚宝药业集团股份有限公司关于续聘会计师事务所的公告 | 2026-05-07 | Chinese | |
| 亚宝药业集团股份有限公司关于召开2025年年度股东会的通知 | 2026-05-07 | Chinese | |
| 亚宝药业集团股份有限公司关于购买董事、高级管理人员责任险的公告 | 2026-05-07 | Chinese | |
| 亚宝药业集团股份有限公司第九届董事会第十四次会议决议公告 | 2026-05-07 | Chinese | |
| 亚宝药业集团股份有限公司关于取得药品注册证书的公告 | 2026-04-20 | Chinese |
Browse filings by year
25 years- 2026 9 filings
- 2025 88 filings
- 2024 78 filings
- 2023 79 filings
- 2022 52 filings
- 2021 62 filings
- 2020 79 filings
- 2019 62 filings
- 2018 80 filings
- 2017 62 filings
- 2016 83 filings
- 2015 117 filings
- 2014 48 filings
- 2013 48 filings
- 2012 48 filings
- 2011 43 filings
- 2010 47 filings
- 2009 48 filings
- 2008 51 filings
- 2007 39 filings
- 2006 39 filings
- 2005 33 filings
- 2004 27 filings
- 2003 17 filings
- 2002 15 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 46364326 | 亚宝药业集团股份有限公司关于参加山西辖区上市公司2026年投资者网上集体接待日活动的公告 | 2026-05-15 | Chinese | ||
| 44271695 | 亚宝药业集团股份有限公司关于续聘会计师事务所的公告 | 2026-05-07 | Chinese | ||
| 44271682 | 亚宝药业集团股份有限公司关于召开2025年年度股东会的通知 | 2026-05-07 | Chinese | ||
| 44270672 | 亚宝药业集团股份有限公司关于购买董事、高级管理人员责任险的公告 | 2026-05-07 | Chinese | ||
| 44267232 | 亚宝药业集团股份有限公司第九届董事会第十四次会议决议公告 | 2026-05-07 | Chinese | ||
| 40773859 | 亚宝药业集团股份有限公司关于取得药品注册证书的公告 | 2026-04-20 | Chinese | ||
| 40773858 | 亚宝药业集团股份有限公司2025年三季度权益分派实施公告 | 2026-01-29 | Chinese | ||
| 40773849 | 亚宝药业集团股份有限公司2026年第一次临时股东会律师见证法律意见书 | 2026-01-16 | Chinese | ||
| 40773827 | 亚宝药业集团股份有限公司2026年第一次临时股东会决议公告 | 2026-01-16 | Chinese | ||
|
2025
6 filings
| |||||
| 40773821 | 亚宝药业集团股份有限公司2026年第一次临时股东会会议资料 | 2025-12-24 | Chinese | ||
| 40773818 | 亚宝药业集团股份有限公司关于出售子公司股权进展暨完成工商变更登记的公告 | 2025-12-22 | Chinese | ||
| 40773816 | 亚宝药业集团股份有限公司2025年三季度利润分配方案公告 | 2025-12-19 | Chinese | ||
| 40773811 | 亚宝药业集团股份有限公司关于召开2026年第一次临时股东会的通知 | 2025-12-19 | Chinese | ||
| 40773803 | 亚宝药业集团股份有限公司第九届董事会第十二次会议决议公告 | 2025-12-19 | Chinese | ||
| 40773799 | 亚宝药业集团股份有限公司关于GLX002获得药物临床试验批准通知书的公告 | 2025-12-17 | Chinese | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Yabao Pharmaceutical Group Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56668/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56668 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56668 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56668 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56668}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Yabao Pharmaceutical Group Co.,Ltd (id: 56668)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.